Zhejiang Jianye Chemical Co., Ltd. (SHA:603948)
China · Delayed Price · Currency is CNY 28.49
-0.07 (-0.25%)
At close: Feb 13, 2026
Zhejiang Jianye Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 2,082 | 2,296 | 2,561 | 2,707 | 2,723 | 1,681 |
Other Revenue | 98.57 | 98.57 | 88.64 | 89.14 | 76.4 | 48.08 |
| 2,180 | 2,394 | 2,650 | 2,796 | 2,799 | 1,729 | |
Revenue Growth (YoY) | -12.60% | -9.64% | -5.24% | -0.12% | 61.94% | 3.16% |
Cost of Revenue | 1,848 | 2,067 | 2,151 | 2,157 | 2,299 | 1,495 |
Gross Profit | 332.45 | 326.92 | 499.01 | 638.57 | 500.03 | 233.27 |
Selling, General & Admin | 53.41 | 79.02 | 93.2 | 104.89 | 86.17 | 60.7 |
Research & Development | 38.77 | 31.18 | 36.52 | 97.63 | 96.21 | 55.96 |
Other Operating Expenses | -0.98 | -17.09 | 8.05 | 14.33 | 6.86 | 3.57 |
Operating Expenses | 89.62 | 90.74 | 140.69 | 216.24 | 190.95 | 119.1 |
Operating Income | 242.82 | 236.18 | 358.33 | 422.33 | 309.08 | 114.17 |
Interest Expense | -0.07 | -0.07 | -0.08 | -0.07 | -0.05 | -0.25 |
Interest & Investment Income | 20.61 | 11.62 | 17.92 | 16.42 | 12.73 | 15.77 |
Currency Exchange Gain (Loss) | 1.95 | 1.95 | 1.39 | 5.01 | -2.67 | -5.19 |
Other Non Operating Income (Expenses) | -4.46 | -0.32 | -0.37 | -0.42 | -0.6 | -0.74 |
EBT Excluding Unusual Items | 260.86 | 249.37 | 377.19 | 443.26 | 318.49 | 123.75 |
Impairment of Goodwill | -0.72 | -0.72 | -0.38 | -0.38 | -0.35 | - |
Gain (Loss) on Sale of Assets | 0.57 | 0.54 | -1.95 | -0.13 | 0.08 | -5.99 |
Asset Writedown | -4.62 | -5.2 | - | - | -2.58 | - |
Other Unusual Items | 7.97 | 7.97 | 11.01 | 11.95 | 13.9 | 27.06 |
Pretax Income | 264.05 | 251.95 | 385.88 | 454.7 | 329.53 | 144.82 |
Income Tax Expense | 45.58 | 42.9 | 68.19 | 64.45 | 39.51 | 19.14 |
Net Income | 218.47 | 209.06 | 317.68 | 390.24 | 290.02 | 125.69 |
Net Income to Common | 218.47 | 209.06 | 317.68 | 390.24 | 290.02 | 125.69 |
Net Income Growth | -10.44% | -34.19% | -18.59% | 34.56% | 130.75% | -11.82% |
Shares Outstanding (Basic) | 162 | 162 | 160 | 160 | 160 | 153 |
Shares Outstanding (Diluted) | 162 | 162 | 160 | 160 | 160 | 153 |
Shares Change (YoY) | 0.44% | 1.01% | 0.32% | -0.19% | 4.54% | 27.97% |
EPS (Basic) | 1.35 | 1.29 | 1.98 | 2.44 | 1.81 | 0.82 |
EPS (Diluted) | 1.35 | 1.29 | 1.98 | 2.44 | 1.81 | 0.82 |
EPS Growth | -10.84% | -34.85% | -18.85% | 34.81% | 120.73% | -31.09% |
Free Cash Flow | 347.74 | 260.71 | 283.88 | 329.3 | 88.96 | 67.76 |
Free Cash Flow Per Share | 2.15 | 1.61 | 1.77 | 2.06 | 0.56 | 0.44 |
Dividend Per Share | 1.000 | 1.000 | 1.000 | 1.920 | 0.550 | 0.450 |
Dividend Growth | - | - | -47.92% | 249.09% | 22.22% | - |
Gross Margin | 15.25% | 13.65% | 18.83% | 22.84% | 17.86% | 13.49% |
Operating Margin | 11.14% | 9.87% | 13.52% | 15.10% | 11.04% | 6.60% |
Profit Margin | 10.02% | 8.73% | 11.99% | 13.96% | 10.36% | 7.27% |
Free Cash Flow Margin | 15.95% | 10.89% | 10.71% | 11.78% | 3.18% | 3.92% |
EBITDA | 307.89 | 305.02 | 432.18 | 496.17 | 367.66 | 161.57 |
EBITDA Margin | 14.12% | 12.74% | 16.31% | 17.75% | 13.13% | 9.35% |
D&A For EBITDA | 65.07 | 68.83 | 73.85 | 73.84 | 58.57 | 47.4 |
EBIT | 242.82 | 236.18 | 358.33 | 422.33 | 309.08 | 114.17 |
EBIT Margin | 11.14% | 9.87% | 13.52% | 15.10% | 11.04% | 6.60% |
Effective Tax Rate | 17.26% | 17.03% | 17.67% | 14.17% | 11.99% | 13.21% |
Revenue as Reported | 2,180 | 2,394 | 2,650 | 2,796 | 2,799 | 1,729 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.